Company Search:
Advanced Search
Sponsored Links
China Animal Husbandry Ind. Company Snapshot
China Animal Husbandry Ind. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares China Animal Husbandry Ind. with three other companies in this sector in CHINA : China Biologic Products Holdings Inc (2019 sales of 3.48 billion Chinese Renmimbi [US$500.37 million] of which 84% was Biopharmaceutical Products), Hualan Biological Engineering Inc (3.70 billion Chinese Renmimbi [US$532.68 million] of which 71% was Blood Product), and Beijing Tiantan Biologic. (3.28 billion Chinese Renmimbi [US$472.49 million] of which 100% was Blood products).

Sales Analysis. During the year ended December of 2019, sales at China Animal Husbandry Ind. were 4.12 billion Chinese Renmimbi (US$592.83 million). This is a decrease of 7.1% versus 2018, when the company's sales were 4.43 billion Chinese Renmimbi. The sales level in 2019 was fairly close to the level five years ago: in 2014, China Animal Husbandry Ind. had sales of 4.03 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 10.2% decline in Animal Disease Treatment, from 903.68 million Chinese Renmimbi to 811.09 million Chinese Renmimbi. There were also decreases in sales in Animal Feedstuff (down 4.7% to 2.14 billion Chinese Renmimbi) and Animal Disease and Epidemic Prevention (down 9.3% to 1.14 billion Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Other (up 0.7% to 29.49 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
China Animal Husbandry Ind.
  Stock Performance Chart for China Animal Husbandry Ind.
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 16.85
(Figures in Chinese Renmimbi)
1 Week -0.9%   13 Weeks 12.9%  
4 Weeks 31.6%   52 Weeks 60.1%  
China Animal Husbandry Ind. Key Data:
  Ticker: 600195 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 4,117,720,022
(Year Ending Jan 2020).
Employees: 4,120
  Currency: Chinese Renmimbi Market Cap: 17,017,670,190
  Fiscal Yr Ends: December Shares Outstanding: 842,408,000
  Share Type: A Gu Closely Held Shares: 624,337,824
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.